HM Sampoerna to Launch HEETS Factory in West Java.

Nov.15.2022
HM Sampoerna to Launch HEETS Factory in West Java.
Indonesia's tobacco company HM Sampoerna invests $166 million in a HEETS e-cigarette plant in West Java.

According to the Indonesian business publication Bisnis Indonesia, a HEETS electronic cigarette factory worth $166 million is set to launch in West Java by the end of this year.


HM Sampoerna has announced that they will provide production facilities for IQOS cigarette sticks. This information was sourced from Bisnis Indonesia.


One of Indonesia's largest tobacco companies, HM Sampoerna (which controls 34% of the domestic market and is owned by Phillip Morris International), has announced the launch of a high-tech HEETS cigarette production factory for IQOS in the city of Karawang in West Java Province in the fourth quarter of 2022, with an investment of $166 million.


The factory will supply both domestic and export markets in the Asia-Pacific region," said Vassilis Gkatzelis, director of PT HM Sampoerna Tbk. He added, "The launch of the Karawang factory confirms PMI's optimistic outlook for the Indonesian and Asian markets." Vassilis emphasized that "Indonesia is an important investment destination for us, and we have high confidence in this country.


For PMI, the new factory is the second in Asia (with the first one located in South Korea) and the eighth worldwide. The products of HM Sampoerna are currently produced by 44 contract factories and are supplied to over 40 overseas markets.


Globally, IQOS is showing a positive trend of growth. As of the end of the third quarter of 2022, there are over 19.5 million adult IQOS users across 70 countries. In Indonesia, the number of IQOS users has surpassed 65,000, representing a more than doubled increase since 2020.


Statement:


This article is compiled from third-party information and is intended for industry-related communication and learning purposes only.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity or accuracy of the content. The compilation of this article is only intended for communication and research within the industry.


As a result of limitations in translation skills, this article may not fully express the same sentiment as the original. Please refer to the original text for accuracy.


2FIRSTS is totally aligned with the stance and expressions of the Chinese government regarding anything involving domestic, Hong Kong, Macau, Taiwan, and foreign affairs.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us to have it removed.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Marty Makary briefly appeared at the February 10 PMTA roundtable, underscoring the importance of regulatory predictability. At the close of the session, Office of Science Director Matthew Farrelly responded to industry concerns over review uncertainty, stating the agency will issue a written summary of feedback, while reiterating that no fixed quantitative risk benchmark governs authorization decisions.
Feb.11
FDA PMTA Roundtable: Ongoing Comprehensive Coverage by 2Firsts
FDA PMTA Roundtable: Ongoing Comprehensive Coverage by 2Firsts
Feb.11
KDCA youth panel: health indicators worsen with grade level; liquid e-cigarette use tops cigarettes among 11th-grade students
KDCA youth panel: health indicators worsen with grade level; liquid e-cigarette use tops cigarettes among 11th-grade students
Korea Disease Control and Prevention Agency’s Youth Health Panel Survey (2025) Final Results Report says key adolescent health indicators worsen as students move up grade levels. By 11th grade, lifetime tobacco experience rose to 9.59%. Among 11th-grade girls, current use of liquid e-cigarettes (1.54%) surpassed conventional cigarettes (1.33%) for the first time.
Feb.10 by 2FIRSTS.ai
Moldova adopts new sanitary rules for tobacco products, e-cigarettes and related goods
Moldova adopts new sanitary rules for tobacco products, e-cigarettes and related goods
Moldova is introducing new sanitary standards for tobacco products, e-cigarettes and related goods, with regulations adopted on January 14 aimed at protecting public health and tightening control over tobacco sales. The rules include measures to limit minors’ access to tobacco products, including via online shops, and establish procedures for notifications, reporting and market monitoring.
Jan.16 by 2FIRSTS.ai
IQOS Partners with Mexico’s Zamna Festival; PMI Says Adult User Base Tops 140,000
IQOS Partners with Mexico’s Zamna Festival; PMI Says Adult User Base Tops 140,000
Philip Morris International (PMI) said IQOS, via its “IQOS Curious X” platform, has entered a global partnership with the Zamna music festival in Tulum, Mexico, with the collaboration making its on-site debut during Zamna 2026 and targeting adult nicotine users. PMI said IQOS has more than 34 million users worldwide, while the number of adult consumers in Mexico has surpassed 140,000.
Jan.15 by 2FIRSTS.ai
PMI Faces Setback in India: Global Regulatory Fragmentation Complicates Its Smoke-Free Transition
PMI Faces Setback in India: Global Regulatory Fragmentation Complicates Its Smoke-Free Transition
India has reaffirmed its 2019 ban on e-cigarettes and heated tobacco devices, effectively blocking Philip Morris International (PMI) from launching IQOS in the country despite years of lobbying. Together with Taiwan, China’s conditional opening of heated tobacco products, and Japan’s planned 2026 excise tax hikes, these moves highlight increasingly divergent national regulatory pathways—an external uncertainty shaping PMI’s smoke-free growth trajectory.
Feb.12